Milosz Gruca
Corporate Officer/Principal chez SELVITA S.A.
Fortune : 1 M $ au 31/03/2024
Profil
Milosz Gruca is currently a Member of the Management Board at BioCentrum Sp zoo and the Chief Commercial Officer & Executive VP at Selvita SA. Previously, he served as a Member of the Management Board at Ryvu Therapeutics SA from 2007 to 2014.
Dr. Gruca holds a graduate and doctorate degree from Uniwersytet Jagiellonski, an MBA from Cracow University of Economics, and another MBA from Stockholm Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SELVITA SA
0,33% | 08/11/2022 | 60 760 ( 0,33% ) | 1 M $ | 31/03/2024 |
Postes actifs de Milosz Gruca
| Sociétés | Poste | Début |
|---|---|---|
| SELVITA S.A. | Corporate Officer/Principal | 01/01/2007 |
BioCentrum Sp zoo
 BioCentrum Sp zoo Miscellaneous Commercial ServicesCommercial Services BioCentrum Sp zoo is a biotechnology company, which engages in the provision of preclinical development services and products. It also offers absorption, distribution, metabolism, and excretion testing; and behavioural studies. The company was founded in 2004 and is headquartered in Krakow, Poland. | Corporate Officer/Principal | - |
Anciens postes connus de Milosz Gruca
| Sociétés | Poste | Fin |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Corporate Officer/Principal | - |
Formation de Milosz Gruca
| Uniwersytet Jagiellonski | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
BioCentrum Sp zoo
BioCentrum Sp zoo Miscellaneous Commercial ServicesCommercial Services BioCentrum Sp zoo is a biotechnology company, which engages in the provision of preclinical development services and products. It also offers absorption, distribution, metabolism, and excretion testing; and behavioural studies. The company was founded in 2004 and is headquartered in Krakow, Poland. | Commercial Services |
| Selvita SA |
